Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

Aug 20, 2026 - Highlights a philanthropic program in 9 states to ensure rural hospitals have access to generic drugs during drug shortages. Discusses how the pilot program will offer rural hospitals more consistency in drug availability, potential cost savings, and the goal to offer the program nationally.
Source: The Daily Yonder
Aug 14, 2026 - Offers an interview with a community pharmacist discussing the role pharmacies play in overcoming healthcare and vaccine access challenges for rural communities.
Source: Drug Topics
Aug 5, 2026 - A new pharmacy has opened in a rural Wisconsin community. Discusses the access challenges the community has previously faced and the advantages of participating in a network of pharmacies.
Source: WKBT
Aug 3, 2026 - Notice from the Health Resources and Services Administration (HRSA) announcing the availability of a revised 340B Rebate Model Pilot Program (Pilot). The Pilot provides a rebate mechanism through which qualifying drug manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities. Eligible manufacturers seeking to participate in the 340B Rebate Model Pilot Program must submit plans to 340BPricing@hrsa.gov by August 24, 2026, for an effective date of January 1, 2027.
Source: Federal Register
Jul 31, 2026 - Describes a heart failure care program in rural West Virginia pharmacies. The program includes care coordination between local pharmacists and cardiovascular specialists to support consistent care and identify medication-related concerns early for rural patients.
Source: WVU Medicine
Jul 31, 2026 - Announces the revised 340B Rebate Model Pilot Program to use a claims-based rebate approach. Eligible manufacturers must submit rebate plans by August 24, 2026 for pricing periods effective January 1, 2027.
Source: Health Resources & Services Administration
Jul 24, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on the following information collections: 1) Medicare Transaction Facilitator under Sections 11001 and 11002 of the Inflation Reduction Act (IRA) and 2) Collection of Prescription Drug Event Data from Contracted Part D Providers for Payment. Comments are due by September 22, 2026.
Source: Federal Register
Jul 20, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on draft guidance for the Medicare Drug Price Negotiation Program regarding manufacturer effectuation of the maximum fair price in 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA). Comments are due by September 18, 2026.
Source: Federal Register
Jul 16, 2026 - Notice of a proposed rule from the Centers for Medicare & Medicaid Services (CMS) addressing: 1) changes to the Physician Fee Schedule and Medicare Part B payment policies; 2) policies for the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; 3) the Ambulatory Specialty Model; 4) updates to drugs and biological products paid under Part B; 5) Medicare Shared Savings Program requirements; 6) updates to the Quality Payment Program; 7) updates to policies for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs); 8) updates to the Ambulance Fee Schedule regulations; 9) codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2026 provisions; 10) updates to Clinical Laboratory Fee Schedule regulations; and 11) updates to the Medicare Promoting Interoperability Program. Comments are due on September 14, 2026.
Source: Federal Register
Jul 14, 2026 - The Department of Health and Human Services is seeking comments on training and care delivery models to ensure safe and effective use of psychedelic drugs. Questions for consideration include training regarding patient eligibility, drug administration, and post-administration follow up; access for Federally Qualified Health Centers, Certified Community Behavioral Health Clinics, and Rural Health Clinics; and technologies that allow for expanded access while maintaining patient safety. Comments are due August 13, 2026.
Source: Federal Register